1. Home
  2. BC vs LEGN Comparison

BC vs LEGN Comparison

Compare BC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brunswick Corporation

BC

Brunswick Corporation

HOLD

Current Price

$77.34

Market Cap

5.7B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$27.27

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BC
LEGN
Founded
1845
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BC
LEGN
Price
$77.34
$27.27
Analyst Decision
Buy
Strong Buy
Analyst Count
11
12
Target Price
$83.55
$61.33
AVG Volume (30 Days)
656.8K
2.9M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
2.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.81
$42.68
Revenue Next Year
$5.11
$30.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$48.83
$16.24
52 Week High
$90.25
$45.30

Technical Indicators

Market Signals
Indicator
BC
LEGN
Relative Strength Index (RSI) 47.41 59.72
Support Level $74.04 $25.71
Resistance Level $84.25 $29.69
Average True Range (ATR) 2.95 2.10
MACD -0.34 0.01
Stochastic Oscillator 36.78 61.17

Price Performance

Historical Comparison
BC
LEGN

About BC Brunswick Corporation

Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns 442 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: